| P50 | author | Thung-S Lai | Q87605521 |
| P2093 | author name string | Charles S Greenberg | |
| | Cheng-Jui Lin | |
| P2860 | cites work | A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate | Q46226593 |
| | Effects of post-translational modifications catalysed by pollen transglutaminase on the functional properties of microtubules and actin filaments. | Q46242354 |
| | Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination | Q46399177 |
| | Core histones are glutaminyl substrates for tissue transglutaminase | Q46409454 |
| | Histamine H1-receptor of vascular endothelial cells cultured from guinea pig skin | Q46512817 |
| | Hydrolysis of gamma:epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa | Q46650731 |
| | Site-specific transamidation and deamidation of the small heat-shock protein Hsp20 by tissue transglutaminase | Q46873060 |
| | Purification and substrate specificity of transglutaminases from blood and Streptoverticillium mobaraense | Q49205726 |
| | Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. | Q53298621 |
| | A role for tissue transglutaminase in stabilization of membrane-cytoskeletal particles shed from the human placenta. | Q53541406 |
| | Uncovering protein polyamination by the spermine-specific antiserum and mass spectrometric analysis. | Q53671776 |
| | Transglutaminases. | Q53905767 |
| | Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. | Q54019589 |
| | Transglutaminase 2 undergoes a large conformational change upon activation | Q21092747 |
| | Serotonylation of vascular proteins important to contraction | Q21562428 |
| | GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis | Q24292757 |
| | Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling | Q24299806 |
| | Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway | Q24301518 |
| | Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II | Q24323055 |
| | A novel function of tissue-type transglutaminase: protein disulphide isomerase | Q24530143 |
| | Activation of extracellular transglutaminase 2 by thioredoxin | Q24634746 |
| | Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin | Q24680821 |
| | Transglutaminase 2-mediated serotonylation in pulmonary hypertension | Q27027862 |
| | Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity | Q27638096 |
| | Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate | Q27661419 |
| | Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 |
| | Coated-platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors | Q28221893 |
| | Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase | Q28255156 |
| | Mechanism for the inhibition of transglutaminase 2 by cystamine | Q45302748 |
| | Transglutaminase-catalysed incorporation of putrescine into denatured cytochrome. Preparation of a mono-substituted derivative reactive with cytochrome c oxidase | Q46188517 |
| | Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 |
| | Neurodegenerative disease: neuron protection agency | Q28287753 |
| | Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death | Q28287762 |
| | Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines | Q28323408 |
| | Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2 | Q28364936 |
| | Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors | Q28365354 |
| | Synthesis of serotonin by a second tryptophan hydroxylase isoform | Q28513857 |
| | Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia | Q28582000 |
| | Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms | Q28592026 |
| | Polyamines | Q29615154 |
| | Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells | Q33289840 |
| | Transglutaminase regulation of cell function. | Q33707936 |
| | Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes | Q33893946 |
| | Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases | Q33926887 |
| | Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid beta-peptide of amyloid plaques. | Q34025668 |
| | Redox regulation of transglutaminase 2 activity | Q34055808 |
| | Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release | Q34286484 |
| | Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? | Q34460105 |
| | Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway | Q34489967 |
| | Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. | Q34743269 |
| | Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies | Q34763209 |
| | Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine | Q34805750 |
| | Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 |
| | Extracellular TG2: emerging functions and regulation | Q35587161 |
| | Transglutaminase 2: a molecular Swiss army knife | Q35693361 |
| | Writing and Reading the Tubulin Code | Q35837105 |
| | Role of macrophage-derived histamine in atherosclerosis-- chronic participation in the inflammatory response --. | Q35837984 |
| | Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling | Q35921509 |
| | The dynamic dialogue between cells and matrices: implications of fibronectin's elasticity | Q35964046 |
| | Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules | Q36208951 |
| | Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions. | Q36266294 |
| | Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan | Q36312483 |
| | γ-Glutamylamines and neurodegenerative diseases | Q36377238 |
| | Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei | Q36395820 |
| | Transglutaminase 2 in inflammation | Q36486713 |
| | Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models | Q36536417 |
| | Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules | Q36768195 |
| | Tissue transglutaminase and the stress response | Q36772428 |
| | Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length | Q36826440 |
| | Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity | Q36952058 |
| | Increased levels of gamma-glutamylamines in Huntington disease CSF. | Q36952919 |
| | Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system | Q37045225 |
| | Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases | Q37140157 |
| | Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. | Q37258548 |
| | Transglutaminase activation in neurodegenerative diseases. | Q37352964 |
| | Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases | Q37933471 |
| | TGM2 and implications for human disease: role of alternative splicing | Q38070504 |
| | Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin | Q38297514 |
| | Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase | Q38327580 |
| | Serotonylation and Transamidation of Other Monoamines | Q38330010 |
| | Beyond Gene Inactivation: Evolution of Tools for Analysis of Serotonergic Circuitry. | Q38541484 |
| | Specificity of guinea pig liver transglutaminase for amine substrates | Q39246771 |
| | Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E. | Q39387300 |
| | Serotonin--more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin | Q39706367 |
| | Cell-based assay for monitoring transglutaminase activity | Q40510673 |
| | Disrupted spermine homeostasis: a novel mechanism in polyglutamine-mediated aggregation and cell death. | Q40526299 |
| | Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis | Q40594017 |
| | Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases | Q40735275 |
| | Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. | Q40963729 |
| | Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes | Q41766549 |
| | Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4 peptide | Q41830649 |
| | Exposure of βL-crystallin to oxidizing free radicals enhances its susceptibility to transglutaminase activity | Q41884195 |
| | Beta-actin is a target for transglutaminase activity at synaptic endings in chicken telencephalic cell cultures | Q42016431 |
| | Transglutaminase catalyses the modification of glutamine side chains in the C-terminal region of bovine beta-lactoglobulin | Q42111128 |
| | Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease | Q42204907 |
| | Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. | Q42826591 |
| | Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase | Q43577448 |
| | N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease | Q43820046 |
| | Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface | Q43863360 |
| | Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine | Q43873037 |
| | 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease | Q44104440 |
| | Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets | Q44155386 |
| | Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells | Q44195410 |
| | Differential incorporation of biotinylated polyamines by transglutaminase 2. | Q44277951 |
| | Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase | Q44387021 |
| | Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation | Q44389678 |
| | Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. | Q44792358 |
| | Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease. | Q45232035 |
| | Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking | Q45255077 |
| | Paradoxical inhibition of protein aggregation and precipitation by transglutaminase-catalyzed intermolecular cross-linking | Q45282574 |
| P433 | issue | 3 | |
| P304 | page(s) | 501-515 | |
| P577 | publication date | 2016-06-06 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes | |
| P478 | volume | 49 | |